Skip to main content

Table 2 Reproductive data reported at baseline for all women and women with and without incident fracture

From: Early menopause and weight loss are significant factors associated with risk of future fracture in middle-aged women

    

Incident fracture

  
   

No

 

Yes

p-value

   

n = 12,303

 

n = 6023

 
 

na

     

Age at menarche

17,189

 

n (%)

 

n (%)

< 0.001

  < 11

 

(years)

826 (7.2)

 

335 (5.9)

 

 12–15

 

(years)

9731 (84.4)

 

4774 (84.3)

 

  > 16

 

(years)

968 (8.4)

 

555 (9.8)

 

Age at menopause

12,468

    

0.029

  < 40

 

(years)

358 (4.5)

 

172 (3.8)

 

 40–44

 

(years)

776 (9.8)

 

443 (9.8)

 

 45–54

 

(years)

6085 (76.6)

 

3438 (76.0)

 

  > 55

 

(years)

723 (9.1)

 

473 (10.5)

 

Number of born children

17,028

    

0.01

 no children

  

1466 (12.8)

 

756 (13.5)

 

 1–2 children

  

7347 (64.2)

 

3455 (61.8)

 

  ≥ 3 children

  

2628 (23.0)

 

1376 (24.6)

 

Total duration of lactation

18,326

     

 no lactation

 

(months)

3202 (26.0)

 

1623 (26.9)

0.002

 1–6

 

(months)

3918 (31.8)

 

1752 (29.1)

 

 7–18

 

(months)

4180 (34.0)

 

2149 (35.7)

 

  ≥ 19

 

(months)

1003 (8.2)

 

499 (8.3)

 

Age at first delivery

14,794

    

0.007

  ≤ 19

 

(years)

1295 (13.0)

 

542 (11.2)

 

 20–34

 

(years)

8318 (83.5)

 

4121 (85.4)

 

  ≥ 35

 

(years)

354 (3.6)

 

164 (3.4)

 

Ever use of menopausal hormone therapy

7441

(yes)

1336 (26.4)

 

663 (27.8)

0.229

Hysterectomy and/or salpingoophorectomy

7457

(yes)

769 (15.2)

 

396 (16.6)

0.125

Miscarriages > 3

3892

(yes)

249 (9.5)

 

139 (10.9)

0.157

Ever use of oral contraceptives

17,306

(yes)

6049 (49.2)

 

2441 (40.5)

< 0.001

Total use of oral contraceptives

8206

    

0.027

  < 10

 

(years)

3676 (62.8)

 

1525 (64.9)

 

 11–19

 

(years)

1162 (19.8)

 

471 (20.1)

 

  > 20

 

(years)

1020 (17.4)

 

352 (15.0)

 
   

median (Q2-Q4b)

 

median (Q2-Q4b)

 

Start use of oral contraceptives at age

8323

(age)

25.0 (21.0–31.0)

 

27.0 (22.0–34.0)

< 0.001

Reproductive period

12,398

(years)

36.0 (33.0–39.0)

 

36.0 (33.0–39.0)

0.088

Total use of menopausal hormone therapy

1763

(years)

3.0 (2.0–6.0)

 

3.0 (2.0–7.8)

0.004

  1. athe number of valid answers for every question, used for calculating percentages
  2. b values of quartile 2 and 4